| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $7.7M | +43.5% |
| SG&A Expense | $6.6M | -19.1% |
| Operating Income | -$14.0M | -11.5% |
| Interest Expense | $390K | -95.1% |
| Pre-tax Income | -$15.3M | +23.8% |
| Income Tax | $0 | — |
| Net Income | -$15.3M | +23.8% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.0M | -36.3% |
| Current Assets | $8.0M | -36.3% |
| Total Assets | $8.3M | -39.9% |
| Current Liabilities | $4.5M | +18.7% |
| Stockholders' Equity | $3.7M | -62.0% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | -49.6% |
| Capital Expenditures | $81K | -90.6% |
| Investing Cash Flow | -$81K | +90.6% |
| Financing Cash Flow | $5.9M | -27.7% |
| Free Cash Flow | -$10.4M | -34.2% |